GFRA1 Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to GFRA1 Antibody

GFRA1 antibodies are biologics designed to bind specifically to the GFRA1 receptor, which is overexpressed in malignancies like breast cancer and osteosarcoma while showing limited expression in normal tissues . These antibodies are primarily investigated as components of antibody-drug conjugates (ADCs) for targeted cancer therapy, leveraging GFRA1’s rapid internalization properties for payload delivery .

Preclinical Development and Mechanisms

  • Internalization Kinetics: Anti-GFRA1 antibodies (e.g., 10H9) exhibit rapid internalization, with >80% of target-positive cells internalizing the antibody within 30 minutes, enabling efficient delivery of cytotoxic payloads like pyrrolobenzodiazepine (PBD) dimers or monomethyl auristatin E (MMAE) .

  • Antigen Shedding: Soluble GFRA1 levels in patient serum range from 0.9–28 ng/ml, but this does not impede ADC efficacy in preclinical models .

Therapeutic Applications in Breast Cancer

  • Target Expression:

    • Luminal A Breast Cancer: 70% of cases show high GFRA1 expression, making it a priority for ADC development .

    • Triple-Negative Breast Cancer (TNBC): 23% of TNBC tumors express GFRA1, a novel finding with therapeutic implications .

  • Efficacy:

    • GFRA1-vcMMAE ADCs induced tumor regression in MCF7 and KPL-1 xenograft models .

    • In patient-derived xenografts (PDXs), GFRA1-PBD ADCs demonstrated activity at receptor densities ≥50,000/cell .

GFRA1 in Other Cancers

  • Osteosarcoma: GFRA1 promotes cisplatin resistance via autophagy mediated by the SRC-AMPK pathway. Co-treatment with chloroquine (an autophagy inhibitor) and cisplatin reduced tumor volume in preclinical models .

  • Prognostic Marker: High GFRA1 expression correlates with lymph node metastasis, advanced disease stage, and poor survival in breast cancer .

Current Research and Future Directions

  • Clinical Trials: No human trials reported yet, but rodent and primate pharmacokinetic data support further development .

  • Combination Therapies: Potential synergy with autophagy inhibitors (e.g., chloroquine) or chemotherapies is under exploration .

Product Specs

Buffer
Liquid in PBS containing 50% glycerol, 0.5% BSA, and 0.02% sodium azide.
Form
Liquid
Lead Time
Generally, we can ship the products within 1-3 business days after receiving your order. The delivery time may vary depending on the purchase method or location. Please consult your local distributors for specific delivery time information.
Synonyms
GDNF family receptor alpha 1 antibody; GDNF family receptor alpha-1 antibody; GDNF R antibody; GDNF RA antibody; GDNF receptor alpha antibody; GDNF receptor alpha-1 antibody; GDNFR alpha 1 antibody; GDNFR alpha antibody; GDNFR antibody; GDNFR-alpha-1 antibody; GDNFRA antibody; GDNFRalpha antibody; GFR alpha 1 antibody; GFR alpha1 antibody; GFR-alpha-1 antibody; GFRA 1 antibody; Gfra1 antibody; GFRA1_HUMAN antibody; GFRalpha1 antibody; Glial cell line derived neurotrophic factor receptor alpha antibody; GPI linked anchor protein antibody; MGC23045 antibody; PI linked cell surface accessory protein antibody; RET 1L antibody; RET ligand 1 antibody; RET1L antibody; RETL 1 antibody; RETL1 antibody; TGF beta related neurotrophic factor receptor 1 antibody; TGF-beta-related neurotrophic factor receptor 1 antibody; TRNR 1 antibody; TRNR1 antibody
Target Names
GFRA1
Uniprot No.

Target Background

Function
GFRA1 acts as a receptor for GDNF. It mediates the GDNF-induced autophosphorylation and activation of the RET receptor.
Gene References Into Functions
  1. circGFRA1 may function as a competing endogenous RNA (ceRNA) to regulate GFRA1 expression through sponging miR-34a, thereby exerting regulatory functions in TNBC. PMID: 29037220
  2. The methylation status of CpG sites in GFRA1 and GSTM2 may play a role and could be used as potential biomarkers for rectal cancer screening. PMID: 27566576
  3. GFRA1 regulates AMPK-dependent autophagy by promoting SRC phosphorylation independent of proto-oncogene RET kinase. PMID: 27754745
  4. The consequences of this are that GFRalpha-1-mediated signaling is altered during the aging process. PMID: 27346872
  5. RET c.1296A may be a common susceptibility allele for nephron underdosing-related diseases. The 5'-UTR and intronic variants near exon 5 of GFRA1 are not associated with nephron endowment. PMID: 27533506
  6. Hox proteins coordinate motor neuron differentiation and connectivity programs through Ret/Gfra genes. PMID: 26904955
  7. This study demonstrates, using a knock-in mouse model in which GFRalpha1 is no longer located in lipid rafts, that the developmental functions of GDNF in the periphery require the translocation of the GDNF receptor complex into lipid rafts. PMID: 26400951
  8. Methylation changes of GFRA1, SRF, and ZNF382 may be a potential biomarker set for predicting gastric carcinoma metastasis. PMID: 25009298
  9. GFRalpha1 levels in neurons from autopsied AD brains are significantly decreased. PMID: 25253858
  10. In the cochlea, GFRalpha-1 was mainly identified in the cell bodies of the spiral neurons. In the organ of Corti, GFRalpha-1 was demonstrated in the Deiters' cells, Hensen cells, inner pillar cells, and weakly in inner hair cells but not in the outer hair cells. PMID: 24139947
  11. The study shows co-localization of RET with GFRA1 and GFRA2 in myenteric ganglia of the adult human colon. PMID: 23881409
  12. The expression of GFRalpha1 and/or GFRalpha3, especially when combined with ARTN expression, may be useful predictors of disease progression and outcome in specific subtypes of mammary carcinoma. PMID: 23351331
  13. Mutations in the GFRA1 gene are associated with urinary tract malformations. PMID: 22729463
  14. Post-synaptic transgenic GFRalpha1 has profound effects on the development of dopamine neurons, resulting in a 40% increase in the adult number. PMID: 21133924
  15. This study found nominally-significant evidence for interactions between GFRA1, 2 and 3 associated with schizophrenia and clozapine response, consistent with the locations of these three genes within linkage regions for schizophrenia. PMID: 20116071
  16. Results identify persephin, a GDNF family member, as a novel ligand for the GFRalpha1/RET receptor complex. PMID: 20350599
  17. MEN2 arises from activating missense mutations in RET, causing autodimerization under certain conditions. The position of missense mutations influences medullary thyroid carcinoma aggressiveness. Review. PMID: 20669561
  18. Here we report that human nigral dopaminergic neurons express GFRalpha1 and RET receptors at all ages. There was no reduction in the number of neurons expressing these receptors as a function of age. PMID: 20347960
  19. GFR-alpha1 mRNA transcripts were detected in oocytes and GCs from all samples from fetuses, girls and adult women. PMID: 19896648
  20. The expression of GFRA1 in normal infants and normoganglionic colon of patients with Hirschsprung's disease was restricted to receptor tyrosine kinase(RET)-negative glial cells and RET-positive neurons of the ganglionic plexus. PMID: 12065680
  21. GFRA1-193C > G and 537T > C could be in linkage disequilibrium with other loci responsible for medullary thyroid cancer. PMID: 12490080
  22. Analysis of the binding surface for the GDNF-GFR alpha 1. PMID: 14514671
  23. GFRalpha-1 were observed within sensory and motor nuclei of cranial nerves, dorsal column nuclei, olivary nuclear complex, reticular formation, pontine nuclei, locus caeruleus, raphe nuclei, substantia nigra, and quadrigeminal plate. PMID: 17825269
  24. GDNF can act as an important component of the inflammatory response in breast cancers, and its effects are mediated by GFR alpha 1 receptors. PMID: 18089803
  25. GDNF is a key component for preserving several cell populations in the nervous system and also participates in the survival and differentiation of peripheral neurons. PMID: 18394855
  26. 38 cases of germ cell tumors: 26 cases contained immature teratoma, of which 24 had immature neuroepithelium and showed strong membrane staining for GFRalpha-1. Staining for GFRalpha-1 in immature neuroepithelium may facilitate its identification. PMID: 19019765
Database Links

HGNC: 4243

OMIM: 601496

KEGG: hsa:2674

STRING: 9606.ENSP00000393725

UniGene: Hs.388347

Protein Families
GDNFR family
Subcellular Location
Cell membrane; Lipid-anchor, GPI-anchor. Golgi apparatus, trans-Golgi network. Endosome. Endosome, multivesicular body.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.